Genetic analysis of a malignant meningioma and associated metastases
Sign Up to like & getrecommendations! Published in 2022 at "Acta Neurochirurgica"
DOI: 10.1007/s00701-021-05101-w
Abstract: To identify genes altered in a highly aggressive metastatic meningioma primary as well as its metastases. Exome sequencing of a primary anaplastic meningioma and metastatic lesions in which DNA could be extracted and compared to… read more here.
Keywords: meningioma; genetic analysis; meningioma associated; analysis malignant ... See more keywords
Clinical factors and outcomes of malignant meningioma: a population-based study
Sign Up to like & getrecommendations! Published in 2022 at "Neurological Research"
DOI: 10.1080/01616412.2022.2056343
Abstract: ABSTRACT Objective We aimed to investigate prognostic factors and outcomes of malignant meningioma and to construct a nomogram model of survival. Methods Patients with malignant meningioma were collected from the Surveillance, Epidemiology, and End Results… read more here.
Keywords: clinical factors; outcomes malignant; meningioma population; factors outcomes ... See more keywords
Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells
Sign Up to like & getrecommendations! Published in 2021 at "Bioengineered"
DOI: 10.1080/21655979.2021.1885864
Abstract: ABSTRACT Chrysophanol shows promising antitumor activity, but how it may work against malignant meningioma is poorly understood. In addition, osteoglycin (OGN) may help mediate the antitumor effects of chrysophanol; thus, this study investigated the potential… read more here.
Keywords: malignant meningioma; nf2 signaling; viability; mtor ... See more keywords
PO-511 High miR-9 levels represent a novel prognostic biomarker to predict development of malignant meningioma
Sign Up to like & getrecommendations! Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-eacr25.1012
Abstract: Introduction Meningioma is the most common primary tumour affecting the central nervous system; it is classified as benign (WHO I,~80%), atypical (WHO II,~15%–20%) and anaplastic/malignant (WHO III,~1%–3%). The 3 year recurrence rate in WHO I meningioma… read more here.
Keywords: malignant meningioma; 511 high; mir levels; mir ... See more keywords
Prognostic Factors and Treatment Strategies for Elderly Patients with Malignant Meningioma: A SEER Population-Based Study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.913254
Abstract: Objective Malignant meningioma (MM) is a relatively rare disease with poor survival. Few studies had focused on MM in the elderly population. This study aims to explore the prognostic factors and optimal therapeutic strategy in… read more here.
Keywords: prognostic factors; elderly patients; patients receiving; population ... See more keywords